Total Payments
$3,586
2024 Payments
$1,050
Companies
36
Transactions
203
Medicare Patients
6,199
Medicare Billing
$321,598
Payment Breakdown by Category
Food & Beverage$3,411 (95.1%)
Education$175.64 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,411 | 199 | 95.1% |
| Education | $175.64 | 4 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $653.75 | 43 | $0 (2024) |
| PFIZER INC. | $400.83 | 27 | $0 (2024) |
| Antares Pharma, Inc. | $300.73 | 13 | $0 (2024) |
| ABBVIE INC. | $262.96 | 17 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $187.76 | 8 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $162.66 | 10 | $0 (2023) |
| UROVANT SCIENCES INC | $146.80 | 13 | $0 (2022) |
| Merck Sharp & Dohme LLC | $142.83 | 7 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $129.79 | 7 | $0 (2024) |
| SHIELD THERAPEUTICS INC | $128.40 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,050 | 50 | Merck Sharp & Dohme LLC ($142.83) |
| 2023 | $936.79 | 51 | Supernus Pharmaceuticals, Inc. ($187.76) |
| 2022 | $989.04 | 64 | PFIZER INC. ($174.38) |
| 2021 | $610.10 | 38 | Astellas Pharma US Inc ($346.75) |
All Payment Transactions
203 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Incyte Corporation | PEMAZYRE (Drug), JAKAFI, MONJUVI | Food and Beverage | Cash or cash equivalent | $21.58 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Neurology | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: ONCOLOGY | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/19/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Oncology | ||||||
| 09/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: HEMATOLOGY | ||||||
| 09/03/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Hematology | ||||||
| 08/27/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Oncology | ||||||
| 08/22/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $113.16 | General |
| Category: Hematology | ||||||
| 08/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Oncology | ||||||
| 06/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,596 | 2,261 | $308,067 | $80,242 |
| 2022 | 7 | 1,497 | 2,202 | $278,774 | $71,790 |
| 2021 | 10 | 1,585 | 2,544 | $339,846 | $90,176 |
| 2020 | 13 | 1,521 | 2,542 | $399,527 | $79,390 |
Total Patients
6,199
Total Services
9,549
Medicare Billing
$321,598
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 512 | 716 | $186,040 | $49,407 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 234 | 265 | $52,470 | $13,375 | 25.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 11 | 79 | $42,227 | $10,459 | 24.8% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 13 | 46 | $8,706 | $2,383 | 27.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 612 | 896 | $7,246 | $1,956 | 27.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 179 | 215 | $8,067 | $1,558 | 19.3% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 13 | 19 | $1,440 | $719.91 | 50.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 11 | 14 | $1,256 | $287.84 | 22.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 11 | $615.00 | $96.91 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 525 | 782 | $203,320 | $54,053 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 208 | 236 | $46,728 | $11,538 | 24.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 590 | 951 | $8,559 | $2,095 | 24.5% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2022 | 11 | 38 | $8,474 | $1,999 | 23.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 131 | 157 | $8,007 | $1,031 | 12.9% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2022 | 16 | 19 | $2,356 | $920.08 | 39.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 19 | $1,330 | $153.98 | 11.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 511 | 802 | $208,520 | $58,976 | 28.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 194 | 237 | $46,926 | $11,626 | 24.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 11 | 69 | $37,743 | $10,027 | 26.6% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2021 | 16 | 65 | $14,495 | $3,641 | 25.1% |
| 81003 | Automated urinalysis test | Office | 2021 | 549 | 948 | $8,532 | $2,111 | 24.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 230 | 328 | $16,728 | $2,023 | 12.1% |
| 51700 | Bladder irrigation and/or instillation | Office | 2021 | 22 | 23 | $2,852 | $1,113 | 39.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 27 | 37 | $2,590 | $325.44 | 12.6% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2021 | 11 | 15 | $1,320 | $264.29 | 20.0% |
About Lindsay Montgomery, PA-C
Lindsay Montgomery, PA-C is a Physician Assistant healthcare provider based in Ashland, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2010. The National Provider Identifier (NPI) number assigned to this provider is 1750692489.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lindsay Montgomery, PA-C has received a total of $3,586 in payments from pharmaceutical and medical device companies, with $1,050 received in 2024. These payments were reported across 203 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($3,411).
As a Medicare-enrolled provider, Montgomery has provided services to 6,199 Medicare beneficiaries, totaling 9,549 services with total Medicare billing of $321,598. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Ashland, KY
- Active Since 06/28/2010
- Last Updated 04/24/2024
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750692489
Products in Payments
- XTANDI (Drug) $672.08
- XYOSTED (Drug) $279.47
- Xtandi (Drug) $233.18
- LUPRON DEPOT (Drug) $225.55
- NOCDURNA (Drug) $209.02
- GEMTESA (Drug) $201.46
- Nubeqa (Drug) $162.66
- KEYTRUDA (Biological) $142.83
- XIAFLEX (Biological) $129.79
- ACCRUFER (Drug) $128.40
- PROLARIS (Device) $86.54
- AQUABEAM ROBOTIC SYSTEM (Device) $68.61
- Enhertu (Drug) $67.09
- Myrbetriq (Drug) $53.81
- Axonics (Device) $47.63
- Udenyca (Biological) $43.07
- Orserdu (Drug) $42.01
- NINLARO (Drug) $37.53
- VENCLEXTA (Drug) $37.41
- GENTLECATH (Device) $32.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Ashland
Sara Everman, Pa-C, PA-C
Physician Assistant — Payments: $9,080
Physician Assistant $9,080
Gregory Moore, Pa-C, PA-C
Physician Assistant — Payments: $4,271
Physician Assistant $4,271
Dustin Adkins, Pa, PA
Physician Assistant — Payments: $3,623
Physician Assistant $3,623
Angela Pannuti, Pa-C, PA-C
Physician Assistant — Payments: $3,068
Physician Assistant $3,068
Deann Brown, Pa-C, Caq-Psych, PA-C, CAQ-PSYCH
Physician Assistant — Payments: $2,989
Physician Assistant $2,989
Danielle Ashley, Pa-C, PA-C
Physician Assistant — Payments: $2,850
Physician Assistant $2,850